Statement period
ANGEN
ANGEN dataANGEN
Anatolia Tanı ve Biyoteknoloji
Loaded balance sheet line
Loaded balance sheet line
Loaded income statement line
Shareable report
Share image
One image for social sharing. If statement rows are missing, it only shows profile and market status.
GOLDEN BAZAARBIST Company Financial Report
ANGEN
Anatolia Tanı ve Biyoteknoloji
Total assets2.6B TRY
Equity1.7B TRY
F/K-
PD/DD-
Net profit-145.4M TRY
Company information
Legal nameAnatolia Tanı ve Biyoteknoloji Ürünleri Araştırma Geliştirme Sanayi ve Ticaret A.Ş.
SectorBiyoteknoloji ve tanı kitleri
MarketBIST 500
Cityİstanbul
Foundation / registry date2010-06-11
IPO date15 Oct 2021
First trading date21 Oct 2021
Websitehttps://www.anatoliageneworks.com
Income statement
2026/3 vs 2025/12
| Line | Loaded | Previous | Change |
|---|---|---|---|
| Net period profit | -145.4M | -312.7M | +53.50% |
Balance sheet
2026/3 vs 2025/12
| Line | Loaded | Previous | Change |
|---|---|---|---|
| Total assets | 2.6B | 2.4B | +10.12% |
| Equity | 1.7B | 1.7B | +0.62% |
Deep financial data
Shows periods inside the company's listed timeline. Pre-listing periods are not counted as missing.
27 rows
Deep financial data
Shows periods inside the company's listed timeline. Pre-listing periods are not counted as missing.
Balance sheet
Assets, liabilities, debt, and equity by reporting period.
2 lines9 periods shown
| Financial line | 2026/3 | 2025/12 | 2025/9 | 2025/6 | 2025/3 | 2024/12 | 2024/9 | 2024/6 | 2024/3 | Last period change |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.6B | 2.4B | 2.1B | 2.0B | 1.9B | 1.8B | 1.7B | 1.6B | 1.5B | +10.12% |
| Equity | 1.7B | 1.7B | 1.7B | 1.6B | 1.6B | 1.6B | 1.5B | 1.4B | 1.3B | +0.62% |
Income statement
Revenue, margin, operating profit, and net profit trend.
1 lines9 periods shown
| Financial line | 2026/3 | 2025/12 | 2025/9 | 2025/6 | 2025/3 | 2024/12 | 2024/9 | 2024/6 | 2024/3 | Last period change |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Period Profit | -145.4M | -312.7M | -294.6M | -202.0M | -105.3M | -218.9M | -187.9M | -107.5M | -60.2M | +53.50% |